James R. Turchen

Array ( [id] => 3411888 [patent_doc_number] => 05443983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Method of culturing lymphocytes and method of treatment using such lymphocytes' [patent_app_type] => 1 [patent_app_number] => 7/170755 [patent_app_country] => US [patent_app_date] => 1988-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5795 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443983.pdf [firstpage_image] =>[orig_patent_app_number] => 170755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2681018 [patent_doc_number] => 05045467 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-03 [patent_title] => 'Serum-free growth medium and use thereof' [patent_app_type] => 1 [patent_app_number] => 7/142069 [patent_app_country] => US [patent_app_date] => 1988-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2298 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/045/05045467.pdf [firstpage_image] =>[orig_patent_app_number] => 142069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2644536 [patent_doc_number] => 04980290 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-12-25 [patent_title] => 'Human uroepithelial cell' [patent_app_type] => 1 [patent_app_number] => 7/106310 [patent_app_country] => US [patent_app_date] => 1987-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2831 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/980/04980290.pdf [firstpage_image] =>[orig_patent_app_number] => 106310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2968420 [patent_doc_number] => 05194256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-16 [patent_title] => 'Purified human cytomegalovirus protein' [patent_app_type] => 1 [patent_app_number] => 7/104392 [patent_app_country] => US [patent_app_date] => 1987-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3927 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/194/05194256.pdf [firstpage_image] =>[orig_patent_app_number] => 104392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2884487 [patent_doc_number] => 05213970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-25 [patent_title] => 'Method for obtaining soluble antitumor factor' [patent_app_type] => 1 [patent_app_number] => 7/006814 [patent_app_country] => US [patent_app_date] => 1987-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 10783 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/213/05213970.pdf [firstpage_image] =>[orig_patent_app_number] => 006814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3065200 [patent_doc_number] => 05352664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Thrombin derived polypeptides; compositions and methods for use' [patent_app_type] => 1 [patent_app_number] => 6/925201 [patent_app_country] => US [patent_app_date] => 1986-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 8259 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352664.pdf [firstpage_image] =>[orig_patent_app_number] => 925201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2880366 [patent_doc_number] => 05185432 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-09 [patent_title] => 'Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas' [patent_app_type] => 1 [patent_app_number] => 6/834172 [patent_app_country] => US [patent_app_date] => 1986-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7496 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/185/05185432.pdf [firstpage_image] =>[orig_patent_app_number] => 834172 [rel_patent_id] =>[rel_patent_doc_number] =>)